Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurol India ; 71(Supplement): S183-S188, 2023.
Article in English | MEDLINE | ID: mdl-37026351

ABSTRACT

Background: The standard therapy for glioblastoma (GBM) has been external beam radiotherapy (EBRT) with concomitant temozolomide (TMZ) given for six cycles, after maximum possible surgical resection although recurrences after chemoradiation are mostly in-field. Objective: To compare the effects of early GKT (without EBRT) along with TMZ to those receiving standard chemoradiotherapy (EBRT + TMZ) after surgery. Methods: This was a retro-prospective study on histologically proven GBMs operated at our center between January 2016 and November 2018. The EBRT group consisted of 24 patients who received EBRT + TMZ for six cycles. The GKT arm consisted of 13 consecutive patients who received Gamma Knife within 4 weeks of surgery along with lifelong temozolomide. Patients were followed up every 3 months with CEMRI brain and PET-CT. The primary endpoint was overall survival (OS) with progression-free survival (PFS) being the secondary endpoint. Results: At a mean follow-up of 13.7 months, the median overall survivals in GKT and EBRT groups were 11.07 and 13.03 months, respectively (HR = 0.59; P value = 0.19; 95% CI: 0.27-1.29). The median PFS for GKT group was 7.03 months (95% CI: 4.17-17.3) as compared to 11.07 months (95% CI: 5.33-14.03) for the EBRT group. There was no statistical difference in the PFS or OS between the GKT and EBRT groups. Conclusion: Our study shows that Gamma Knife therapy (without EBRT) to residual tumor/tumor bed after primary surgery with concurrent temozolomide has similar progression-free (PFS) and overall survival (OS) rates when compared to conventional treatment (EBRT).


Subject(s)
Brain Neoplasms , Glioblastoma , Radiosurgery , Humans , Glioblastoma/surgery , Glioblastoma/drug therapy , Temozolomide/therapeutic use , Prospective Studies , Positron Emission Tomography Computed Tomography , Brain Neoplasms/surgery , Brain Neoplasms/drug therapy , Antineoplastic Agents, Alkylating/therapeutic use
3.
Neurol India ; 70(2): 515-519, 2022.
Article in English | MEDLINE | ID: mdl-35532612

ABSTRACT

Background and Introduction: The interhemispheric transcallosal approach provides an elegant pathway to access the lesions of the third ventricle. However, every step of this approach is fraught with hazards which must be negotiated delicately. A comprehensive knowledge of surgical anatomy coupled with technical skill is necessary for optimum surgical results. Objective: This video aims to address the surgical nuances of the suprachoroidal transcallosal approach while accessing the lesions around the foramen of Monro in the anterior and middle part of the third ventricle. Surgical Technique: A 16-year-old boy presented with worsening headaches with episodes of speech arrest and blank stare for 6 years, which had become more frequent over the past 4-5 months. Radiology showed a subcentimeteric colloid cyst at the foramen of monro. A transcallosal corridor was used to reach the foramen of monro, and the suprachoroidal access was adopted to uncover the colloid cyst and excise it completely preserving the deep veins. Results: The patient had uneventful recovery and radiology showed complete excision of the cyst. Conclusion: Transcallosal approach, being minimally invasive, exploits the natural extra-axial corridor (interhemispheric) obviating the need for a cortical incision. The suprachoroidal approach mitigates the risks of thalamostriate vein injury, basal ganglia stroke, and hemiparesis.


Subject(s)
Cerebral Veins , Colloid Cysts , Third Ventricle , Adolescent , Cerebral Veins/anatomy & histology , Colloid Cysts/diagnostic imaging , Colloid Cysts/surgery , Corpus Callosum/diagnostic imaging , Corpus Callosum/surgery , Humans , Male , Third Ventricle/diagnostic imaging , Third Ventricle/pathology , Third Ventricle/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...